HealthDay.com

Potential disparities in uptake seen by socioeconomic status and locality among privately insured adults

Better remission and response seen with bright light therapy before four weeks and after four weeks

Fear also tied to worse mental and physical health

Cumulative incidence of full cognitive recovery higher with postoperative SRS versus WBRT and for SRS alone versus SR + WBRT

Regardless of one or two doses, mpox antibodies wane by six to 12 months

No differences seen for quality of life and tumor control with localized prostate cancer

Only musculoskeletal conditions accounted for a greater share of visits

Additional benefits would be seen for extended life expectancy from birth

By Robin Foster HealthDay Reporter FRIDAY, Oct. 4, 2024 (HealthDay News) -- As an outbreak of bird flu among dairy cows continues to spread in...

Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis

Carotid plaque burden and coronary artery calcium score both significantly linked to all-cause mortality in asymptomatic individuals

Ovarian cancer detected with specificity >99 percent and sensitivity ranging from 69 to 100 percent depending on stage

17.4 percent in GLP-1 RA group undergoing esophagogastroduodenoscopies had food retention versus none in the control group

In addition, genetic test may assist in identifying patients more likely to respond

Light gradient boosting machine learning model achieved performance comparing favorably with experienced clinicians